JP2004516234A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004516234A5 JP2004516234A5 JP2001579743A JP2001579743A JP2004516234A5 JP 2004516234 A5 JP2004516234 A5 JP 2004516234A5 JP 2001579743 A JP2001579743 A JP 2001579743A JP 2001579743 A JP2001579743 A JP 2001579743A JP 2004516234 A5 JP2004516234 A5 JP 2004516234A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20156700P | 2000-05-01 | 2000-05-01 | |
| US70233200A | 2000-10-31 | 2000-10-31 | |
| PCT/US2001/013988 WO2001082867A2 (en) | 2000-05-01 | 2001-05-01 | A core formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004516234A JP2004516234A (ja) | 2004-06-03 |
| JP2004516234A5 true JP2004516234A5 (enExample) | 2005-12-22 |
Family
ID=26896877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001579743A Pending JP2004516234A (ja) | 2000-05-01 | 2001-05-01 | コア製剤 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1278513B1 (enExample) |
| JP (1) | JP2004516234A (enExample) |
| AT (1) | ATE367151T1 (enExample) |
| AU (2) | AU2001257456B2 (enExample) |
| CA (1) | CA2407713A1 (enExample) |
| DE (1) | DE60129425T2 (enExample) |
| ES (1) | ES2290130T3 (enExample) |
| WO (1) | WO2001082867A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN192749B (enExample) * | 2002-11-15 | 2004-05-15 | Ranbaxy Lab Ltd | |
| PE20050335A1 (es) * | 2003-08-07 | 2005-06-01 | Sb Pharmco Inc | Forma de dosificacion oral que comprende 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona y procedimiento para la preparacion |
| GB0318824D0 (en) * | 2003-08-11 | 2003-09-10 | Glaxo Group Ltd | Novel composition |
| WO2005065663A1 (en) * | 2003-12-31 | 2005-07-21 | Alpharma, Inc. | Rosiglitazone and metformin formulations |
| EP1732513A2 (en) * | 2003-12-31 | 2006-12-20 | Alpharma, Inc. | Rosiglitazone formulations |
| FR2896159B1 (fr) * | 2006-01-13 | 2008-09-12 | Merck Sante Soc Par Actions Si | Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline. |
| RU2554740C2 (ru) * | 2009-05-01 | 2015-06-27 | Апталис Фарматек, Инк. | Композиции перорально распадающихся таблеток, содержащие комбинации высоко- и низкодозовых лекарственных средств |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166800A (en) * | 1977-08-25 | 1979-09-04 | Sandoz, Inc. | Processes for preparation of microspheres |
| JPH05503934A (ja) * | 1990-01-30 | 1993-06-24 | アクゾ・エヌ・ヴエー | 壁により完全に包囲され、１種以上の活性物質で全部又は一部を充填した中空空間から成る、活性物質の調節送達のための物品 |
| AUPM897594A0 (en) * | 1994-10-25 | 1994-11-17 | Daratech Pty Ltd | Controlled release container |
| US6011049A (en) * | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
| KR20060105005A (ko) * | 1997-06-18 | 2006-10-09 | 스미스클라인비이참피이엘시이 | 티아졸리딘디온 및 메트포르민을 사용한 당뇨병의 치료 |
| US6099862A (en) * | 1998-08-31 | 2000-08-08 | Andrx Corporation | Oral dosage form for the controlled release of a biguanide and sulfonylurea |
| WO2001035940A2 (en) * | 1999-11-16 | 2001-05-25 | Smithkline Beecham P.L.C. | Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride |
| MY125516A (en) * | 1999-11-16 | 2006-08-30 | Smithkline Beecham Plc | Novel composition based on thiazolidinedione and metformin and use |
-
2001
- 2001-05-01 WO PCT/US2001/013988 patent/WO2001082867A2/en not_active Ceased
- 2001-05-01 AT AT01930970T patent/ATE367151T1/de not_active IP Right Cessation
- 2001-05-01 DE DE60129425T patent/DE60129425T2/de not_active Expired - Fee Related
- 2001-05-01 AU AU2001257456A patent/AU2001257456B2/en not_active Ceased
- 2001-05-01 EP EP01930970A patent/EP1278513B1/en not_active Expired - Lifetime
- 2001-05-01 AU AU5745601A patent/AU5745601A/xx active Pending
- 2001-05-01 JP JP2001579743A patent/JP2004516234A/ja active Pending
- 2001-05-01 ES ES01930970T patent/ES2290130T3/es not_active Expired - Lifetime
- 2001-05-01 CA CA002407713A patent/CA2407713A1/en not_active Abandoned